image dons

I make a donation

The ORBITA-COSMIC Trial

CSR - Refractory angina

Publication presented by Ghilas RAHOUAL

On May 21, 2024

Title: Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

Reference: The Lancet, April 2024

Autres actualités

+

17/09/2024


The POPULAR PAUSE TAVI Trial

TAVI - Anticoagulation - Bleeding risks
+

10/09/2024


The NOTION3 Trial

PCI - TAVR
+

03/09/2024


The RESHAPE-HF2 Trial

HF - Mitral regurgitation - Mitra-Clip